Abstract
Human acetylcholine receptor and the Lefvert method (13) were used to determine the serum levels of anti-acetylcholine receptor antibodies in 27 patients with Myasthenia Gravis.
Antibodies were detected in 22 patients (81%). Negative results were generally obtained in patients having milder forms of the disease. To find out whether serum levels of antibodies correlate with the severity of the disease, we compared the median antibody levels in patients with Type 1 and 2A Myasthenia Gravis with those of patients with type 2B and 3. Significantly lower titers were observed in the first group. Nevertheless, there were many overlapping values in the range of each class of the disease. A more definite relationship was observed in the follow-up of single patients. As a rule, clinical deterioration was accompanied by an increase of antibody levels and viceversa.
Sommario
Utilizzando recettore acetilcolinico prelevato da muscolo umano, noi abbiamo seguito il metodo di Lefvert [13] per determinare il livello serico degli anticorpi diretti contro il recettore acetilcolinico in 27 pazienti affetti da Miastenia Grave.
Gli anticorpi erano evidenziati in 22 pazienti (81%). Risultati negativi erano generalmente osservati in pazienti affetti dalle forme più lievi della malattia. Per studiare la possibile relazione tra livello serico anticorpale e severità della malattia abbiamo comparato i valori mediani dei titoli anticorpali in pazienti con Miastenia Grave tipo 1 e 2A nei confronti di quelli misurati in pazienti con Miastenia Grave tipo 2B e 3. Titoli significativamente più bassi erano osservati nel primo gruppo. Tuttavia frequenti sovrapposizioni erano osservate nei range di ciascuna classe della malattia. Una più definita relazione era notata nel follow-up di singoli pazienti. Generalmente il deterioramento clinico era accompagnato da un aumento del livello anticorpale, e viceversa.
Similar content being viewed by others
References
Aharonov A., Abramsky O., Tarrab-Hazdai R., Fuchs S.:Humoral antibodies to acetylcholine receptor in patients with myasthenia gravis. Lancet (2) 7930: 340-342, 1975.
Almon R.R., Andrew C.G., Appel S.H.:Serum globulin in myasthenia gravis: Inhibition of alpha Bungarotoxin binding to Acetylcholine receptors. Science 186: 55–57, 1974.
Almon R.R., Appel S.H.:Interaction of myasthenic serum globulin with the acetylcholine receptor. Biochem. Biophys. Acta 393: 66–77, 1975.
Appel S.H., Almon R.R., Levy N.:Acetylcholine receptor antibodies in myashenia gravis. N. Engl. J. Med. 293 (15): 760–761, 1975.
De Crousaz G., Fulpius B., Monnier V., Regli F.:Dosage des anticorps dirigés contre le récepteur nicotinique de l'acetylcholine: corrélations clinicoimmunologiques chez 30 myasthéniques. Schweiz. Med. Wschr. 108: 602–607, 1978.
Drachman D.B., Angus W.C., Adams R.N., Michelson J.D., Hoffman G.J.:Myasthenic antibodies cross-link acetylcholine receptors to accelerate degradation. N. Engl. J. Med. 298: 1116–1122, 1978.
Drachman D.B., Adams R.N., Stanley E.F., Pestron K.A.:Mechanism of acetylcholine receptor loss in myasthenia gravis. J. Neurol. Neurosurg. Psychiat. 43: 601–610, 1980.
Fambrough D.M., Drachman D.B., Satyamuati S.:Neuromuscular junction in myasthenia gravis: decreased acetylcholine receptors. Science 182: 293–295, 1973.
Heilbronn E., Lefvert A.K., Stalberg E.:Acetylcholine receptor antibodies in the diagnosis of human and experimental myasthenia gravis: Muscle & Nerve 1: 427–431, 1978.
Heilbronn E., Stalberg E.:The pathogenesis of myasthenia gravis. J. Neurochem. 31: 5–11, 1978.
Hunter W.M., Greenwood F.C.:Preparation of iodine 131 I labelled growth hormone of high specific activity. Nature (London) 194: 495–496, 1962.
Lefvert A.K., Mattel G.:Antibodies against human cholinergic receptor proteins in patients with Myasthenia Gravis: studies during immunosuppressive treatment. Acta Med. Scand. 201: 181–182, 1977.
Lefvert A.K., Bergstrom K., Mattel G., Osterman P.O., Pirskanen R.:Determination of acetylcholine receptor antibodies in myasthenia gravis: clinical usefulness and pathogenic implications. J. Neurol. Neurosurg. Psychiat. 41: 394–401, 1978.
Lindstrom J.M., Lennon V., Seybold M.E., Whittingham S.:Experimental autoimmune myasthenia gravis and myasthenia gravis: biochemical and immunochemical aspects. Ann. NY Acad. Sci. 274: 254–274, 1976.
Lindstrom J.M., Seybold M.E., Lennon V.A., Wittingham S., Duane D.:Antibody to acetylcholine receptor in myasthenia gravis. Neurology 26: 1054–1059, 1976.
Lindstrom J.M.:Immunological studies of acetylcholine receptors. J. Supramol. Struct. 4: 384–403, 1976.
Lindstrom J.:An assay for antibodies to human acetylcholine receptor in serum from patients with Myasthenia Gravis. Clin. Immunol. Immunopathol. 7: 36–43, 1977.
Lindstrom J., Campbell M., Nave B.:Specificities of antibodies to acetylcholine receptors. Muscle & Nerve 1: 140–145, 1978.
Mittag T., Kornfeld P., Tormay A. Wco C.:Detection of anti-acetylcholine receptors factors in serum and thymus from patients with myasthenia gravis. N. Engl. J. Med. 294: 691–694, 1976.
Monnier V.M., Fulpius B.W.:A radioimmunoassay for the quantitative evaluation of anti-human acetylcholine receptor antibodies in myasthenia gravis. Clin. Exp. Immunol. 29: 16–22, 1977.
Newson-Davis J., Pinching A.J., Vincent A., Wilson S.G.:Function of circulating antibody to acetylcholine receptor in Myasthenia Gravis: investigation by plasma-exchange. Neurology 28: 266–272, 1978.
Osserman K.E., Genkins G.:Studies in Myasthenia Gravis: review of a twenty years experience in over 1.200 patients. Mount Sinai J. Med. 38: 497–537, 1971.
Roitt I.:Autoimmunity. p. 265 in Essential Immunology Blackwell Scientific Publ. Oxford, 1977.
Savage-Marengo T., Harrison R., Lunt G.G., Behan P.O.:Patient-specific anti-receptor antibody patterns in myasthenia gravis. J. Neurol. Neurosurg. Psychiat. 43 (4): 316–320, 1980.
Vincent A., Newsom-Davis J.:Anti-acetylcholine receptor antibodies. J. Neurol. Neurosurg. Psychiat. 43: 590–600, 1980.
Zurn A., Fulpius B.W.:Studies of 2 different subpopulations of antiacetylcholine receptor antibodies in a rabbit with experimental autoimmune myasthenia gravis. Eur. J. Immunol. 7: 529–532, 1977.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cerrato, D., Ariano, C., La Mantia, L. et al. Myasthenia Gravis. Anti-acetylcholine receptor antibodies. Ital J Neuro Sci 2, 165–171 (1981). https://doi.org/10.1007/BF02335439
Issue Date:
DOI: https://doi.org/10.1007/BF02335439